SPRY Total Utang marang Modal ARS Corp

Lambang korporat lan logo ARS Pharmaceuticals (SPRY)

ARS Pharmaceuticals faces regulatory delays and competition within the allergy segment. The company's growth relies on the market launch of the painless Neffy spray. Local production in the US completely offsets external political risks. The 7.65 level reflects the current magnitude of the leverage ratio: the ratio of total debt to equity shown on this chart.

SPRY: Total Utang marang Modal ARS Pharmaceuticals, Inc. 28.04.2023 - 28.10.2026

Rincian analitis lan laporan data perusahaan ARS Corp (SPRY)

- rega lan prakiraan konsensus rega:
Bagan rega ARS Pharmaceuticals, Inc.|SPRY - Bagan tingkat prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar ARS Pharmaceuticals|SPRY - Nilai Dipunlarasaken Utang lan Kas
- data kapitalisasi buku:
Nilai Buku saben Saham ARS Pharmaceuticals|SPRY - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku ars-pharma.com|SPRY - Nilai Agregat Aset
- data utang lan likuiditas:
Utang marang Ekuitas ARS Pharmaceuticals|SPRY - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal ARS Pharmaceuticals|SPRY - Gunggung utang perusahaan|Utang marang nilai buku ARS Pharmaceuticals|SPRY - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ARS Pharmaceuticals
Analisis komprehensif perusahaan:SPRY - ARS Pharmaceuticals, Inc.
Produk merek ARS Corp

ARS Pharmaceuticals develops innovative anti-allergen drugs, integrating principles of environmental responsibility into its production cycles. Analyzing this chart of the financing structure (debt-to-equity), one can assess the balance between borrowed funds and equity assets. This metric measures financial leverage, determining the extent of the business's dependence on creditors. A low level of indebtedness confirms the company's stability while implementing strict ESG standards. This reduces default risk, enhancing the investment reliability of the issuer.

Pesaing wigati

Utang marang Ekuitas Haleon HLN|Utang Agregat marang Ekuitas Kenvue Inc|Verona Pharma Corp (VRNA) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Jyong Bio (MENS)|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|amneal.com - Total Utang marang Modal|Utang marang Ekuitas Perrigo (PRGO)|ALVO: Rasio Kabeh Utang marang Dana Pribadi|LQDA (Liquidia Technologies) - Utang marang Ekuitas|Galapagos Corp (GLPG) - Rasio Total Utang marang Ekuitas|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com (MNKD)|Amphastar Pharmaceuticals, Inc. (AMPH) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PCRX (Pacira Pharmaceuticals)|TBPH: Utang marang Ekuitas|AQST - Utang marang Modal|Rasio Total Utang marang Ekuitas scPharma SCPH|TECX - Utang Agregat marang Modal|Total Utang marang Modal Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal EPRX (Eupraxia Pharmaceuticals, Inc.)|Utang marang Modal BHST|eXoZymes Inc (EXOZ) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi oramed.com (ORMP)|Total Utang marang Modal ENTX (Entera Bio)|MindWalk Holdings, Inc. - Total Utang marang Modal|Utang marang Ekuitas ABVC BioPharma Inc (ABVC)|CPIX: Rasio Kabeh Utang marang Dana Pribadi|Quantum BioPharma Ltd - Utang marang Ekuitas|Koefisien Total Utang marang Modal fibrogen.com|TELO - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi RANI|SNYR - Utang marang Ekuitas|Utang Agregat marang Ekuitas rallybio.com (RLYB)|Total Utang marang Modal Lexaria Bioscience Corp.|Rasio Kabeh Utang marang Dana Pribadi pulmatrix.com PULM|Pheton - Total Utang marang Modal|APM: Total Utang marang Modal|Utang marang Ekuitas Lyra Therapeutics, Inc LYRA|IBO (Impact BioMedical, Inc.) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas TNFA|Rasio Total Utang marang Ekuitas cbdMD Corp|Total Utang marang Modal PRFX|Total Utang marang Modal altamiratherapeutics.com (CYTO)|Lipella - Total Utang marang Modal|Rasio Total Utang marang Ekuitas OptiNose Corp OPTN|PIRS (Pieris Pharmaceuticals) - Total Utang marang Modal|procapsgroup.com (PROC) - Utang marang Modal|PTPI: Rasio Total Utang marang Ekuitas|Total Utang marang Modal Qilian International Holding Group|ACELYRIN, Inc. (SLRN) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal TFF Pharmaceuticals, Inc